Results 131 to 140 of about 14,850 (194)

Dapagliflozin enhances gut barrier function in rats with chronic myocardial infarction by modulating gut microbiota balance. [PDF]

Ann Transl Med
Kunasol C, Maneechote C, Apaijai N, Thonusin C, Parbao C, Nawara W, Chattipakorn N, Chattipakorn SC.   +7 more
europepmc   +1 more source

Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Acute Kidney Injury Post Off-Pump Coronary Artery Bypass Grafting: A Retrospective Cohort Study and Meta-Analysis. [PDF]

Rev Cardiovasc Med
Zhou X, Pan Y, Hua K, Yang X.
europepmc   +1 more source

Euglycemic Ketoacidosis Induced by Dapagliflozin in a Non-Diabetic Patient With Cardiac Amyloidosis. [PDF]

Clin Case Rep
Hamoud SAS, Harding E.
europepmc   +1 more source

The impact of short-term administration of dapagliflozin on contrast-induced acute kidney injury in patients with type 2 diabetes and renal insufficiency undergoing percutaneous coronary intervention. [PDF]

Front Med (Lausanne)
Yang S, Zhu S, Zhai X, Liu M, Zhang P, Fu N.   +5 more
europepmc   +1 more source

Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction. [PDF]

Cardiol Res
Tsudome R, Suematsu Y, Tashiro K, Ideishi A, Miyazaki M, Yano Y, Arimura T, Hirata T, Fujimi K, Miura SI.   +9 more
europepmc   +1 more source

The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance. [PDF]

Pediatr Diabetes
Attia N, Al Noaim K, Mustafa M, Al Fifi SH, Al Alwan I, Thalange N, Babiker A.   +6 more
europepmc   +1 more source

Dapagliflozin Preserves Peripheral Nerve Structure and Reduces Neuropathic Damage in Streptozotocin-Induced Diabetic Peripheral Neuropathy. [PDF]

Int J Mol Sci
Țucă AM, Preda AN, Târtea G, Hădăreanu DR, Țieranu E, Dan AO, Târtea EA, Greșiță A, Pîrșcoveanu DFV, Sfredel V, Mitran SI.   +10 more
europepmc   +1 more source

Is it Always Safe to Administer RAS Inhibitors to Patients Who Underwent Unilateral Radical Nephrectomy? [PDF]

Case Rep Nephrol
Romano G, Crestani A, Como G, Cucchiaro E, Fiorini N, Colussi G.   +5 more
europepmc   +1 more source

Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial. [PDF]

JACC Adv
Tavares CAM, Azevedo LCP, Guimarães PO, Rea-Neto Á, David-João PG, Campos NS, Amendola CP, Kozesinski-Nakatani AC, Filiponi TC, Almeida GMB, Bergo RR, Lobo SM, Tognon AP, Tavares MS, Silveira FS, Dracoulakis MDA, Biondi RS, Monfardini F, Nieri J, Madrini V, Serpa-Neto A, Bacal F, Lemos PA, Berwanger O, Ezekowitz JA, Zampieri FG, DEFENDER Investigators.   +26 more
europepmc   +1 more source